{"id":12988,"date":"2025-06-30T14:29:17","date_gmt":"2025-06-30T07:29:17","guid":{"rendered":"https:\/\/www.nanovest.io/blog\/?p=12988"},"modified":"2025-06-30T16:27:28","modified_gmt":"2025-06-30T09:27:28","slug":"amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka","status":"publish","type":"post","link":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/","title":{"rendered":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka"},"content":{"rendered":"<p>Dalam langkah yang menandai babak baru dalam terapi penyakit jantung langka, FDA resmi menyetujui perluasan indikasi AMVUTTRA\u00ae (vutrisiran), menjadikannya terapi RNA interference (RNAi) pertama yang terbukti mengurangi kematian kardiovaskular, rawat inap, dan kunjungan darurat akibat gagal jantung pada pasien dewasa dengan transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM).<\/p>\n<p>Kabar ini datang dari Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), pemimpin global di bidang terapi RNAi, yang telah menghabiskan hampir dua dekade meneliti dan mengembangkan pengobatan inovatif berbasis bioteknologi molekuler.<\/p>\n<p>Kini, usaha itu membuahkan hasil yang bisa menyelamatkan puluhan ribu nyawa.<\/p>\n<p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Daftar Isi <\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#Apa_Itu_ATTR-CM_dan_Mengapa_Begitu_Serius\" >Apa Itu ATTR-CM, dan Mengapa Begitu Serius?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#Vutrisiran_Menyasar_Akar_Masalah_dengan_Presisi_Molekuler\" >Vutrisiran Menyasar Akar Masalah dengan Presisi Molekuler<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#Lebih_dari_Sekadar_Obat_Dukungan_Nyata_untuk_Pasien\" >Lebih dari Sekadar Obat Dukungan Nyata untuk Pasien<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#Persetujuan_Global_Menyusul\" >Persetujuan Global Menyusul<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#Titik_Balik_bagi_Pasien_ATTR-CM\" >Titik Balik bagi Pasien ATTR-CM<\/a><\/li><\/ul><\/nav><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Apa_Itu_ATTR-CM_dan_Mengapa_Begitu_Serius\"><\/span><strong>Apa Itu ATTR-CM, dan Mengapa Begitu Serius?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/p>\n<p>ATTR-CM merupakan penyakit degeneratif mematikan yang disebabkan oleh akumulasi protein transthyretin (TTR) yang salah lipat dan membentuk fibril amiloid, menyerang otot jantung secara progresif.<\/p>\n<p>Sekitar 150.000 orang di AS dan lebih dari 300.000 orang secara global menderita penyakit ini kebanyakan belum terdiagnosis atau belum mendapatkan terapi yang efektif.<\/p>\n<p>Penyakit ini sering disalahartikan sebagai gagal jantung biasa pada usia lanjut, hingga akhirnya terlalu terlambat untuk ditangani. Tanpa pengobatan yang efektif, pasien menghadapi risiko penurunan fungsi jantung secara cepat dan kematian dini.<\/p>\n<p><h3><span class=\"ez-toc-section\" id=\"Vutrisiran_Menyasar_Akar_Masalah_dengan_Presisi_Molekuler\"><\/span><strong>Vutrisiran Menyasar Akar Masalah dengan Presisi Molekuler<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/p>\n<p>AMVUTTRA (vutrisiran) bekerja dengan teknologi RNAi mematikan gen penghasil TTR sebelum protein salah lipat terbentuk. Dengan hanya empat suntikan subkutan per tahun, pasien dapat secara signifikan menurunkan kadar TTR dalam darah, memperlambat bahkan menghentikan proses amiloidosis.<\/p>\n<p>Dalam uji klinis HELIOS-B fase 3, AMVUTTRA menunjukkan:<\/p>\n<p>*   Penurunan risiko kematian sebesar 36% dalam 42 bulan.  <\/p>\n<p>    \u00a0<br \/>\n*   Penurunan rawat inap kardiovaskular sebesar 28\u201333%.  <\/p>\n<p>    \u00a0<br \/>\n*   Peningkatan kualitas hidup, fungsi fisik, dan biomarker kardiovaskular (NT-proBNP, troponin I).  <\/p>\n<p>    \u00a0<br \/>\n*   Tidak ada temuan efek samping baru, menegaskan profil keamanannya.  <\/p>\n<p>    \u00a0<\/p>\n<p>Hasil lengkap studi ini telah dipublikasikan di\u00a0<em>The New England Journal of Medicine<\/em> dan dipresentasikan pada\u00a0<em>European Society of Cardiology Congress<\/em> dua forum paling kredibel di dunia kedokteran.<\/p>\n<p><h3><span class=\"ez-toc-section\" id=\"Lebih_dari_Sekadar_Obat_Dukungan_Nyata_untuk_Pasien\"><\/span><strong>Lebih dari Sekadar Obat Dukungan Nyata untuk Pasien<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/p>\n<p>Alnylam tak hanya menawarkan obat, tetapi juga membangun sistem dukungan penuh lewat Alnylam Assist\u00ae, program yang membantu pasien dari proses akses asuransi, edukasi, hingga dukungan keuangan.<\/p>\n<p>Menariknya, lebih dari 99% pasien hATTR-PN telah tercakup asuransi dan mayoritas tidak membayar biaya pribadi. Model ini kemungkinan besar juga berlaku untuk pasien ATTR-CM, mengingat data klinis dan dinamika payer yang serupa.<\/p>\n<p><h3><span class=\"ez-toc-section\" id=\"Persetujuan_Global_Menyusul\"><\/span><strong>Persetujuan Global Menyusul<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/p>\n<p>Tak berhenti di FDA, Alnylam telah mengajukan perizinan internasional di berbagai otoritas regulasi, termasuk:<\/p>\n<p>*   <strong>European Medicines Agency (EMA)<\/strong>  <\/p>\n<p>    \u00a0<br \/>\n*   <strong>ANVISA (Brazil)<\/strong>  <\/p>\n<p>    \u00a0<br \/>\n*   <strong>PMDA (Jepang)<\/strong>  <\/p>\n<p>    \u00a0<\/p>\n<p>Dengan jalur percepatan di beberapa negara, kemungkinan pasien global akan segera mendapatkan akses ke terapi ini dalam waktu dekat.<\/p>\n<p><h3><span class=\"ez-toc-section\" id=\"Titik_Balik_bagi_Pasien_ATTR-CM\"><\/span><strong>Titik Balik bagi Pasien ATTR-CM<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/p>\n<p>Persetujuan FDA terhadap AMVUTTRA sebagai pengobatan ATTR-CM bukan hanya kemenangan ilmiah ini adalah momen harapan. Seperti yang disampaikan oleh Dr. Ronald Witteles dari Stanford University, \u201cPasien bisa hidup lebih lama, lebih baik, dan lebih bebas dari rumah sakit.\u201d<\/p>\n<p>Dan untuk komunitas penderita ATTR amyloidosis yang selama ini merasa diabaikan, ini adalah sinyal bahwa perubahan nyata sedang terjadi. Muriel Finkel, Presiden\u00a0<em>Amyloidosis Support Groups<\/em>, menyebutnya \u201csebuah momen penting\u201d dan \u201csuar harapan.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[309],"class_list":["post-12988","post","type-post","status-publish","format-standard","category-berita","tag-alnylam-pharmaceuticals"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Nona dari Nanovest\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest\" \/>\n\t\t<meta property=\"og:description\" content=\"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-06-30T07:29:17+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-06-30T09:27:28+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nanovest\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:title\" content=\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@nanovest_io\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"position\":2,\"name\":\"Berita\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#listItem\",\"name\":\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#listItem\",\"position\":3,\"name\":\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#newsarticle\",\"name\":\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest\",\"headline\":\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka\",\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#articleImage\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"datePublished\":\"2025-06-30T14:29:17+07:00\",\"dateModified\":\"2025-06-30T16:27:28+07:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#webpage\"},\"articleSection\":\"Berita, Alnylam Pharmaceuticals\",\"dateline\":\"Published on Juni 30, 2025.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\",\"name\":\"Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#organizationLogo\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nanovest\",\"https:\\\/\\\/twitter.com\\\/nanovest_io\",\"https:\\\/\\\/www.instagram.com\\\/nanovest.io\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5Y5fD2FApTWMc0c2mlxzIg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nano-vest\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/admin\\\/\",\"name\":\"Nona dari Nanovest\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cropped-logo-nanovest-rectangle-96x96.png\",\"width\":96,\"height\":96,\"caption\":\"Nona dari Nanovest\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#webpage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/\",\"name\":\"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest\",\"description\":\"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2025-06-30T14:29:17+07:00\",\"dateModified\":\"2025-06-30T16:27:28+07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"name\":\"Nanovest\",\"alternateName\":\"Blog Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest<\/title>\n\n","aioseo_head_json":{"title":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest","description":"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.","canonical_url":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","position":1,"name":"Home","item":"https:\/\/www.nanovest.io/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","position":2,"name":"Berita","item":"https:\/\/www.nanovest.io/blog\/category\/berita\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#listItem","name":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#listItem","position":3,"name":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka","previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}}]},{"@type":"NewsArticle","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#newsarticle","name":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest","headline":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka","author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/#articleImage","width":250,"height":250,"caption":"site-logo-color"},"datePublished":"2025-06-30T14:29:17+07:00","dateModified":"2025-06-30T16:27:28+07:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#webpage"},"isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#webpage"},"articleSection":"Berita, Alnylam Pharmaceuticals","dateline":"Published on Juni 30, 2025."},{"@type":"Organization","@id":"https:\/\/www.nanovest.io/blog\/#organization","name":"Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","url":"https:\/\/www.nanovest.io/blog\/","logo":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#organizationLogo","width":250,"height":250,"caption":"site-logo-color"},"image":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/nanovest","https:\/\/twitter.com\/nanovest_io","https:\/\/www.instagram.com\/nanovest.io\/","https:\/\/www.youtube.com\/channel\/UC5Y5fD2FApTWMc0c2mlxzIg","https:\/\/www.linkedin.com\/company\/nano-vest\/"]},{"@type":"Person","@id":"https:\/\/www.nanovest.io/blog\/author\/admin\/#author","url":"https:\/\/www.nanovest.io/blog\/author\/admin\/","name":"Nona dari Nanovest","image":{"@type":"ImageObject","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#authorImage","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2025\/07\/cropped-logo-nanovest-rectangle-96x96.png","width":96,"height":96,"caption":"Nona dari Nanovest"}},{"@type":"WebPage","@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#webpage","url":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/","name":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest","description":"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/#website"},"breadcrumb":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/#breadcrumblist"},"author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/admin\/#author"},"creator":{"@id":"https:\/\/www.nanovest.io/blog\/author\/admin\/#author"},"datePublished":"2025-06-30T14:29:17+07:00","dateModified":"2025-06-30T16:27:28+07:00"},{"@type":"WebSite","@id":"https:\/\/www.nanovest.io/blog\/#website","url":"https:\/\/www.nanovest.io/blog\/","name":"Nanovest","alternateName":"Blog Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","inLanguage":"id-ID","publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas","og:type":"article","og:title":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest","og:description":"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.","og:url":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/","article:published_time":"2025-06-30T07:29:17+00:00","article:modified_time":"2025-06-30T09:27:28+00:00","article:publisher":"https:\/\/www.facebook.com\/nanovest","twitter:card":"summary_large_image","twitter:site":"@nanovest_io","twitter:title":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka - Blog Nanovest","twitter:description":"Dengan teknologi RNAi, AMVUTTRA terbukti menurunkan kematian kardiovaskular dan memperbaiki kualitas hidup pasien ATTR-CM. Persetujuan FDA jadi tonggak penting terapi molekuler.","twitter:creator":"@nanovest_io"},"aioseo_meta_data":{"post_id":"12988","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-05-17 04:16:40","breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":null,"created":"2025-06-30 08:52:51","updated":"2026-05-17 04:16:40","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/category\/berita\/\" title=\"Berita\">Berita<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tAMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.nanovest.io/blog"},{"label":"Berita","link":"https:\/\/www.nanovest.io/blog\/category\/berita\/"},{"label":"AMVUTTRA Resmi Disetujui FDA, Ubah Lanskap Pengobatan Penyakit Jantung Langka","link":"https:\/\/www.nanovest.io/blog\/berita\/amvuttra-resmi-disetujui-fda-ubah-lanskap-pengobatan-penyakit-jantung-langka-12988\/"}],"_links":{"self":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/12988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/comments?post=12988"}],"version-history":[{"count":1,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/12988\/revisions"}],"predecessor-version":[{"id":13464,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/12988\/revisions\/13464"}],"wp:attachment":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media?parent=12988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/categories?post=12988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/tags?post=12988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}